Brii Biosciences Limited
BRIBFOTCHealthcare● Active
$0.23
+$0.08(+48.78%)
Market Cap$166736137
P/E Ratio—
52W High$0.26
52W Low$0.1495
Brii Biosciences Limited (BRIBF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BRIBF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $18.12M | $49.94M | $0.62M | $51.63M | $92.54M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.00M | $49.94M | $0.62M | $51.63M | $92.54M |
| Gross Margin %(computed) | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $206.76M | $249.85M | $402.70M | $440.63M | $494.62M |
| G&A Expenses | $0.00M | $153.16M | $55.69M | $53.47M | $79.31M |
| Total Operating Expenses | $308.44M | $453.79M | $545.35M | $565.81M | $703.02M |
| Operating Income | ($295.91M) | ($403.85M) | ($544.30M) | ($513.85M) | ($610.48M) |
| Operating Margin %(computed) | — | -808.74% | — | -995.32% | -659.68% |
| Interest Income | $50.21M | $84.79M | $108.02M | $37.20M | $6.49M |
| Interest Expense | $1.91M | $0.00M | $0.49M | $0.85M | $1.18M |
| Income Before Tax | ($216.43M) | ($512.38M) | ($184.37M) | ($489.78M) | ($4191.08M) |
| Income Tax Expense | $1.85M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($216.88M) | ($508.16M) | ($174.83M) | ($484.31M) | ($4120.23M) |
| Net Margin %(computed) | — | — | — | -938.12% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.30 | $-0.70 | $-0.24 | $-0.67 | $-9.48 |
| Wtd Avg Shares | 721.87M | 730.25M | 728.10M | 723.48M | 439.05M |
| EBITDA | ($290.31M) | ($401.61M) | ($168.20M) | ($503.58M) | ($602.80M) |
| EBITDA Margin %(computed) | — | -804.25% | — | -975.45% | -651.38% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CNY · M
Explore more Brii Biosciences Limited data
About Brii Biosciences Limited (BRIBF) Income Statement
Brii Biosciences Limited (BRIBF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BRIBF reported revenue of $0.02B, gross profit of $0.00B (gross margin 0.00%), and net income of ($0.22B) — a net profit margin of -1196.58%.
Frequently asked questions
BRIBF · 4 questionsBrii Biosciences Limited (BRIBF) reported revenue of $0.02B for 2025, down 63.7% year-over-year.
BRIBF revenueBRIBF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09